Due to the widespread use of isotretinoin (13-cis-retinoic acid) for differentiation induction treatments following NB in clinical settings 47, the binding orientation and affinity between 13-cis-retinoic acid and AL1A2 (a protein coded by ALDH1A2) were further investigated. Here, ALDH1A2 is linked to neuroblastoma.